Pricing Platform Skills Contact
Evidence intelligence for pharma

Evidence-grade answers, in minutes — every claim cited.

Systematic reviews, competitive intelligence, and medical-affairs briefs, built directly from the primary literature. Not a chatbot that sounds confident — an auditable evidence engine that shows its sources.

100% of claims cited 30+ sources per run Deterministic retrieval across 16 databases
Illustrative — your answers stream live, with real current citations and their own certainty rating.
Built on the primary record PubMedClinicalTrials.govOpenAlex openFDAChEMBLEurope PMC
The evidence gap
6–12 weeks

to produce a single systematic review — while competitive and medical-affairs intelligence stays scattered across dozens of databases.

The answer usually exists. Finding it, trusting it, and acting on it is the bottleneck.

  • Manual retrieval and screening burn weeks per review.
  • CI, KOL, congress, and payer signals live in separate tools.
  • Generic AI gives you confident answers you can't verify or defend to MLR.
How it works

Ask in plain language. Get a cited, defensible brief.

Evidara retrieves and structures the primary literature deterministically — then synthesizes on top, grounded so it can't contradict the evidence.

01

Ask

Pose a clinical or business question — a drug, an indication, a competitor, a review protocol.

02

Retrieve & structure

Broad, deterministic search across PubMed, trials, OpenAlex, FAERS and more — fully logged.

03

Act & share

An auditable brief — every claim cited to a PMID — that you export, or share as a public link in one click.

The data underneath

Every brief is built on the world's primary evidence.

One engine, querying the canonical sources directly — deterministically, with every record traceable to a stable identifier.

40M+
Peer-reviewed literature
PubMed + Europe PMC, refreshed continuously
535K+
Registered clinical trials
ClinicalTrials.gov — status & results
16M+
FAERS safety reports
openFDA adverse-event surveillance
250M+
Scholarly works & KOLs
OpenAlex author & institution graph
Plus RxNorm & ChEMBL normalization · bring your own PDFs · every record cited to a stable ID
One engine, every evidence workflow

From systematic review to the boardroom slide.

Systematic literature review

Broad retrieval, AI-assisted screening, and PRISMA tracking — human-in-the-loop, built for HTA-grade defensibility, not a black-box shortcut.

Deterministic search · PRISMA · GRADE · exportable
Records identified3,412
After dedup & screenfocused set
Included studiestraced to PMIDs
Modecomprehensive

Competitive & medical-affairs intelligence

CI briefs, KOL maps, congress activity, and pipeline threats — plus an agentic chat that searches the literature itself and answers with citations.

CI briefs · KOL (OpenAlex) · congress · agentic chat
Akero → Novo acquisition~$5B deal
Head-to-head ITC surfacedADA 2026
KOL #1 (bibliometric)flagged for review
Outputcited · shareable

HEOR & market access

Evidence summaries, payer briefs, and structured EU HTA / Joint Clinical Assessment intelligence — comparator strategy and evidence gaps, ready for the dossier.

SoF · payer briefs · EU HTA/JCA overlays
JCA PICO / comparatormapped
Uncertainty flagssurrogate endpoint
Launch implicationDE/FR divergence
Artifactexport → PPTX/PDF
Why Evidara

Built for evidence you can defend.

Auditable by design

Every number and claim traces to a PMID, trial ID, or named source. Defensible to medical, legal, and regulatory review.

Deterministic retrieval

The retrieval layer runs no LLM — it's reproducible, and every record traces to a stable identifier before any synthesis begins.

Agentic, not a chatbot

The chat acts: it searches PubMed and FAERS itself, then answers grounded on the fresh evidence — and turns it into an exportable brief.

Shareable in one click

Every brief becomes a branded, cited link a colleague can open — no login, no copy-paste. Evidence that travels.

The First Question

Why not just use ChatGPT or a general AI?

Live, not memorized

Every chat answer runs a fresh PubMed/Europe PMC and FAERS query at the moment you ask — never a recall from training data alone.

Citations you can't fake

The model may only cite sources the platform actually retrieved and verified. A raw PMID it types itself is checked separately — and flagged, never accepted as a citation.

Graded, not just generated

Every answer carries a GRADE certainty rating with a documented methodology — including an honest "insufficient evidence" level that's never collapsed into a weak "yes." See how grading works →

Flags what it can't back

In generated writing drafts, unsourced statistics — percentages, hazard ratios, p-values — are flagged for review, never passed through as fact.

See the evidence for yourself.

Run a real review or competitive brief in minutes — every claim cited, nothing to install.

Start free View pricing